Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (66)
Nature (61)
Journal of Perinatology (23)
Pediatric Research (9)
Scientific Reports (5)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (168)
Reviews (8)
Correspondence (4)
Comments & Opinion (3)
Editorial (2)
Research Highlights (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biomarkers
Biotechnology
Cancer
Chemical biology
Diseases
Drug discovery
Endocrinology
Engineering
Evolution
Genetics
Health care
Immunology
Medical research
Microbiology
Oncology
Pathogenesis
Physiology
Risk factors
Scientific community

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 101–150 of 186 results

Advanced filters: Author: H A Burris Clear advanced filters

Therapeutic developments in pancreatic cancer: current and future perspectives

For decades, the 5-year survival for pancreatic cancer remained largely static. In this Review, the authors explore the improvements in pancreatic cancer treatment obtained in the past few years and discuss key questions related to the future development of new therapies.

John P. Neoptolemos
Jörg Kleeff
Daniel H. Palmer
Reviews01 May 2018
Nature Reviews Gastroenterology & Hepatology

Volume: 15, P: 333-348
A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC

V Dieras
B Chevallier
P Fumoleau
Research01 Aug 1996
British Journal of Cancer

Volume: 74, P: 650-656
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

N E Schoemaker
I E L M Kuppens
W W ten Bokkel Huinink
ResearchOpen Access21 Sept 2004
British Journal of Cancer

Volume: 91, P: 1434-1441
A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer

H Anderson
N Thatcher
H Hansen
Research01 Aug 1996
British Journal of Cancer

Volume: 74, P: 460-462
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease

Mutations in the kinase LRRK2 have been linked to Parkinson's disease. Now, Ted Dawson and his colleagues have identified inhibitors of LRRK2 that can reduce LRRK2-induced neurotoxicity in cell culture and in mice.

Byoung Dae Lee
Joo-Ho Shin
Ted M Dawson
Research22 Aug 2010
Nature Medicine

Volume: 16, P: 998-1000
A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer

M Ando
T Watanabe
T Taguchi
Research01 Jun 1998
British Journal of Cancer

Volume: 77, P: 1937-1943
Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines

P Engblom
V Rantanen
S Grènman
ResearchOpen Access18 Dec 1998
British Journal of Cancer

Volume: 79, P: 286-292
Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer

M Ando
K Eguchi
N Saijo
Research01 Dec 1997
British Journal of Cancer

Volume: 76, P: 1494-1499
Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study

R Wilkowski
S Boeck
V Heinemann
ResearchOpen Access10 Nov 2009
British Journal of Cancer

Volume: 101, P: 1853-1859
INFLUENCE OF THROMBIN TREATMENT IN SUSPENSION FOLLOWED BY ACTIVATION UNDER HIGH SHEAR ON BINDING OF vWF BY PLATELET GPIb. ▴ 967

James G White
Marlys D Krumwiede
Gundu H.R Rao
Research01 Apr 1996
Pediatric Research

Volume: 39, P: 164
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism

Selective pharmacological blockade of forebrain excitatory AMPA receptors that express the TARP γ-8 subunit enables antiepileptic therapy in rodent models of epilepsy without inducing motor impairments associated with currently used antiepileptic drugs.

Akihiko S Kato
Kevin D Burris
Jeffrey M Witkin
Research07 Nov 2016
Nature Medicine

Volume: 22, P: 1496-1501
Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma

A Ohtsu
H Baba
T Taguchi
ResearchOpen Access20 Jun 2000
British Journal of Cancer

Volume: 83, P: 141-145
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

F A L M Eskens
C H Mom
E G E de Vries
ResearchOpen Access20 Nov 2007
British Journal of Cancer

Volume: 98, P: 80-85
Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells

C van Bree
H M Rodermond
A B P van Kuilenburg
ResearchOpen Access18 Mar 2008
British Journal of Cancer

Volume: 98, P: 1226-1233
Docetaxel (Taxotere^TM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

A Sulkes
J Smyth
J Verweij
Research01 Aug 1994
British Journal of Cancer

Volume: 70, P: 380-383
Clinical importance of B7-H3 expression in human pancreatic cancer

I Yamato
M Sho
Y Nakajima
ResearchOpen Access20 Oct 2009
British Journal of Cancer

Volume: 101, P: 1709-1716
Changes in preterm birth during the COVID-19 pandemic by duration of exposure and race and ethnicity

Anne M. Mullin
Sara C. Handley
Heather H. Burris
Research16 Aug 2022
Journal of Perinatology

Volume: 42, P: 1346-1352
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

C Yoo
J Y Hwang
J-L Lee
ResearchOpen Access13 Oct 2009
British Journal of Cancer

Volume: 101, P: 1658-1663
Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre

Olusola O Faluyi
Joanna L Connor
Daniel H Palmer
ResearchOpen Access12 Jan 2017
British Journal of Cancer

Volume: 116, P: 424-431
Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m² of CY

C H Weaver
L S Schwartzberg
C D Buckner
Research26 Feb 1999
Bone Marrow Transplantation

Volume: 23, P: 421-425
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)

Sofía Sábato
Susana Benet
He Ping Yeo
ResearchOpen Access22 Mar 2025
Scientific Reports

Volume: 15, P: 1-16
Sequential or alternating administration of docetaxel (Taxotere^®) combined with FEC in metastatic breast cancer: a randomised phase II trial

M Spielmann
M Tubiana-Hulin
J C Eymard
ResearchOpen Access26 Feb 2002
British Journal of Cancer

Volume: 86, P: 692-697
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

F Kullmann
S Hollerbach
E Endlicher
ResearchOpen Access17 Mar 2009
British Journal of Cancer

Volume: 100, P: 1032-1036
A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

M Ikeda
S Okada
T Okusaka
ResearchOpen Access20 May 2002
British Journal of Cancer

Volume: 86, P: 1551-1554
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

J W Valle
H Wasan
J Bridgewater
ResearchOpen Access11 Aug 2009
British Journal of Cancer

Volume: 101, P: 621-627
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

T R J Evans
K W Colston
J L Mansi
ResearchOpen Access26 Feb 2002
British Journal of Cancer

Volume: 86, P: 680-685
A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study

Y Nakai
H Isayama
K Koike
ResearchOpen Access03 May 2012
British Journal of Cancer

Volume: 106, P: 1934-1939
Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

T Okusaka
Y Ito
H Ikeda
ResearchOpen Access29 Jun 2004
British Journal of Cancer

Volume: 91, P: 673-677
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy

T Hamada
Y Nakai
K Koike
ResearchOpen Access18 Mar 2014
British Journal of Cancer

Volume: 110, P: 1943-1949
Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer

K Nakamura
T Yamaguchi
H Saisho
ResearchOpen Access07 Jun 2005
British Journal of Cancer

Volume: 92, P: 2134-2139
Cesarean birth is associated with lower motor and language development scores during early childhood: a longitudinal analysis of two cohorts

Jimena Fritz
Hector Lamadrid-Figueroa
Martha M. Téllez-Rojo
ResearchOpen Access08 Oct 2024
Scientific Reports

Volume: 14, P: 1-12
Racial and ethnic differences in prenatal exposure to environmental phenols and parabens in the ECHO Cohort

Michael S. Bloom
Sudhi Upadhyaya
Lynne M. Smith
ResearchOpen Access15 Feb 2025
Journal of Exposure Science & Environmental Epidemiology

P: 1-11
Associations of salivary aldosterone levels during pregnancy with maternal blood pressure and birth weight-for-gestational age in a Mexico City birth cohort

Oscar Galván-Valencia
Alison P. Sanders
Marcela Tamayo-Ortiz
Research05 Mar 2024
Journal of Perinatology

Volume: 44, P: 643-649
Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network

Geoffrey S. Ginsburg
Larisa H. Cavallari
Sara Van Driest
Research29 Mar 2021
Genetics in Medicine

Volume: 23, P: 1185-1191
Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer

J Millar
P Scullin
M Eatock
ResearchOpen Access08 Nov 2005
British Journal of Cancer

Volume: 93, P: 1112-1116
Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines

J R Kroep
G Giaccone
G J Peters
ResearchOpen Access19 Sept 2000
British Journal of Cancer

Volume: 83, P: 1069-1076
Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study

M Javle
J Yu
R Iyer
ResearchOpen Access02 Jun 2009
British Journal of Cancer

Volume: 100, P: 1842-1845
Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer

H Shinchi
K Maemura
S Takao
ResearchOpen Access17 Apr 2007
British Journal of Cancer

Volume: 96, P: 1353-1357
Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer

K Nakamura
T Yamaguchi
H Saisho
ResearchOpen Access23 May 2006
British Journal of Cancer

Volume: 94, P: 1575-1579
Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer

K Eto
H Kawakami
N Sakamoto
ResearchOpen Access14 Mar 2013
British Journal of Cancer

Volume: 108, P: 1488-1494
Severe maternal morbidity rates in a US-based electronic health record database, 2018–2022

Moeun Son
Jennifer F. Culhane
Kevin Dysart
Research28 Aug 2023
Journal of Perinatology

Volume: 43, P: 1316-1318
Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform

S de Silva
M A Mastrangelo
W J Bowers
Research29 Oct 2009
Gene Therapy

Volume: 17, P: 424-431
Phase I study of temozolomide in paediatric patients with advanced cancer

EJ Estlin
L Lashford
ADJ Pearson
Research01 Sept 1998
British Journal of Cancer

Volume: 78, P: 652-661
Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists

H Sato
S Ishihara
Y Kinoshita
ResearchOpen Access24 Oct 2000
British Journal of Cancer

Volume: 83, P: 1394-1400
Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma

H E R Ford
D Cunningham
L Vernillet
ResearchOpen Access20 Jun 2000
British Journal of Cancer

Volume: 83, P: 146-152
A non-optimal cervicovaginal microbiota in pregnancy is associated with a distinct metabolomic signature among non-Hispanic Black individuals

Kristin D. Gerson
Jingqiu Liao
Michal A. Elovitz
ResearchOpen Access23 Nov 2021
Scientific Reports

Volume: 11, P: 1-12
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

A Younes
J M Vose
M S Czuczman
ResearchOpen Access16 Nov 2010
British Journal of Cancer

Volume: 103, P: 1783-1787
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

Martin H. Voss
Michael S. Gordon
Howard A. Burris III
ResearchOpen Access11 Sept 2020
British Journal of Cancer

Volume: 123, P: 1590-1598
Intermittent dosing of axitinib combined with chemotherapy is supported by ¹⁸FLT-PET in gastrointestinal tumours

C K Hoh
H A Burris III
T R Reid
ResearchOpen Access14 Jan 2014
British Journal of Cancer

Volume: 110, P: 875-881
Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells

S Takano
H Yoshitomi
M Miyazaki
Research26 Nov 2007
Oncogene

Volume: 27, P: 2810-2822